Cargando…
Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2
We previously have described a model of MS in which constitutive expression of murine IL-2 by HSV-1 (HSV-IL-2) causes CNS demyelination in different strains of mice (Zandian et al 2009, IOVS, 50:3275). In the current study, we investigated whether this HSV-IL-2-induced demyelination can be blocked u...
Autores principales: | Zandian, Mandana, Mott, Kevin R., Allen, Sariah J, Dumitrascu, Oana, Kuo, Jane Z, Ghiasi, Homayon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118258/ https://www.ncbi.nlm.nih.gov/pubmed/21412284 http://dx.doi.org/10.1038/gt.2011.32 |
Ejemplares similares
-
IL-2 Suppression of IL-12p70 by a Recombinant HSV-1 Expressing IL-2 Induces T-Cell Auto-Reactivity and CNS Demyelination
por: Zandian, Mandana, et al.
Publicado: (2011) -
Suppression of IL-12p70 formation by IL-2 or following macrophage depletion causes T-cell autoreactivity leading to CNS demyelination in HSV-1-infected mice
por: Lee, Dhong Hyun, et al.
Publicado: (2017) -
Protocol for a mouse CNS demyelination model induced by a combination of HSV-1 and IL-2
por: Hirose, Satoshi, et al.
Publicado: (2021) -
Inclusion of CD80 in HSV Targets the Recombinant Virus to PD-L1 on DCs and Allows Productive Infection and Robust Immune Responses
por: Mott, Kevin R., et al.
Publicado: (2014) -
CD8α Dendritic Cells Drive Establishment of HSV-1 Latency
por: Mott, Kevin R., et al.
Publicado: (2014)